Author: Spadola L. Novellino E. Folkers G. Scapozza L.
Publisher: Elsevier
ISSN: 0223-5234
Source: European Journal of Medicinal Chemistry, Vol.38, Iss.4, 2003-04, pp. : 413-419
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Varicella zoster virus latency
By Eshleman Emily Shahzad Aamir Cohrs Randall J
Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. :
Adalimumab: Varicella zoster virus encephalitis: case report
Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. :
Emerging drugs for varicella-zoster virus infections
By Andrei Graciela Snoeck Robert
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :
Varicella zoster virus vax "well tolerated" in Europe
Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. :